| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2875989 | The Annals of Thoracic Surgery | 2012 | 7 Pages |
Abstract
Using decision analysis, TPC is the preferred treatment for patients with malignant pleural effusion and limited survival; BP is the most cost-effective treatment for patients with more prolonged expected survival.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Varun MD, Tanya L. RHIT, Traves D. MD, Daniel MD, PhD, Alexander S. MD, Graham A. DrPH, G. Alexander MD, Bryan F. MD,